This post was originally published on this site
Eli Lilly announced earnings per share of $2.75 on revenue of $7.44B. Analysts polled by Investing.com anticipated EPS of $2.37 on revenue of $7.26B.
Eli Lilly shares are up 24% from the beginning of the year, still down 1.44% from its 52 week high of $213.20 set on January 26. They are outperforming the S&P 500 which is up 0.83% from the start of the year.
Eli Lilly’s report follows an earnings beat by J&J on Tuesday, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.83 on revenue of $21.69B.
Abbott Labs had beat expectations on Wednesday with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
